Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Torrent Pharma plans...

    Torrent Pharma plans to raise funds via QIP

    Written by savita thakur thakur Published On 2016-03-21T11:16:55+05:30  |  Updated On 21 March 2016 11:16 AM IST
    New Delhi : Drug firm Torrent Pharmaceuticals said it plans to raise funds through various instruments including qualified institutional placements (QIP).

    The company in a filing to the BSE said that its board on March 23 will consider "the proposal for raising of funds by way of issue of equity shares, including convertible bonds or debentures through qualified institutional placements" or any other modes.

    Besides, board will also consider issue of unsecured/secured redeemable non-convertible debentures/bonds by way of private placement.

    However, the company did not elaborate on how much funds it plans to raise.

    Last week, Torrent Pharma had said its third manufacturing plant in Gujarat has obtained the Establishment Inspection Report (EIR) from the US health regulator USFDA.

    "Torrent Pharma has successfully obtained the Establishment Inspection Report from the USFDA for its plant located at Dahej SEZ in Gujarat, the plant has also received approval from the EU Germany," Torrent Pharma had said in a BSE filing.

    With the approval, this plant is now the third plant of Torrent Pharma to receive the USFDA approval, out of its 5 manufacturing plants.

    "The company's other FDA approved plants include the plant at Indrad, Gujarat and Pithampur (Indore), MP," it added.
    Dahej SEZEIREstablishment Inspection ReportQIPqualified institutional placementsTorrentUS Food and Drug AdministrationUSFDA

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok